Monthly newsletter highlights developments in COVID-19 therapeutics via monoclonal antibodies, suggesting importance in health strategies.
January 2022 monthly newsletter for the COVID-19 monoclonal antibody (mAb) Colorado health campaign.
No takes yet. Share an insight, caveat, or question.
Shrader et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: